Haemocell buys fellow UK firm
This article was originally published in Clinica
Executive Summary
Haemocell, which has developed an auto-transfusion system for use during and after surgery, has acquired fellow UK company, Surgical Innovations, in a share swap. Surgical develops minimally invasive surgical instruments, which it a sells under its own name and through OEM agreements with other major companies.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Nominates Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.